Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis

Archives of Neurology

Volumn 70, Issue 1, 2013, Pages 34-43

  Saidha, Shiv ^a,k   Sotirchos, Elias S ^a   Oh, Jiwon ^a   Syc, Stephanie B ^a   Seigo, Michaela A ^a   Shiee, Navid ^b,c,e,g   Eckstein, Chistopher ^a   Durbin, Mary K ^h   Oakley, Jonathan D ^h   Meyer, Scott A ^h   Frohman, Teresa C ⁱ   Newsome, Scott ^a   Ratchford, John N ^a   Balcer, Laura J ^j   Pham, Dzung L ^b,c,g   Crainiceanu, Ciprian M ^d   Frohman, Elliot M ⁱ   Reich, Daniel S ^a,c,d,f   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Neuroimmunology Branch   (United States)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^h CARL ZEISS SMT AG   (Germany)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k MRCPI   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DAMAGE; BRAIN REGION; BRAIN SIZE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINAL NERVE FIBER LAYER THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; WHITE MATTER; BRAIN CORTEX; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; RETINA; RETINA NERVE CELL; AUTOMATION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; HUMAN CELL; HUMAN TISSUE; INTRACRANIAL VOLUME; OUTCOME ASSESSMENT; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY;

ADULT; AXONS; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RETINA; RETINAL NEURONS; TOMOGRAPHY, OPTICAL COHERENCE;

MLCS; MLOWN;

EID: 84872514865     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.573     Document Type: Article

References (43)

1. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain. 2011;134(pt 2): 518-533.
2. Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler. 2011;17(12):1449-1463.
3. Syc SB, Saidha S, Newsome SD, et al. Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain. 2012; 135(pt 2):521-533.
4. Seigo MA, Sotirchos ES, Newsome S, et al. In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques [published online March 15, 2012]. J Neurol. doi:10.1007/s00415-012-6466-x.
5. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol. 2008;4(12):664-675.
6. Saidha S, Eckstein C, Ratchford JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML Mult Scler. 2010;2(2):33-43.
7. Toussaint D, Périer O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol. 1983;3(3):211-220. (Pubitemid 14229303)
8. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology. 1976;26(6, pt 2):26-28.
9. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133(pt 6):1591-1601.
10. Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina. 1994;14(5):445-451.
11. Shindler KS, Ventura E, Dutt M, Rostami A. Inflammatory demyelination induces axonal injury and retinal ganglion cell apoptosis in experimental optic neuritis. Exp Eye Res. 2008;87(3):208-213.
12. Naismith RT, Xu J, Tutlam NT, Trinkaus K, Cross AH, Song SK. Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology. 2010;74 (21):1702-1710.
13. Talman LS, Bisker ER, Sackel DJ, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol. 2010;67(6):749-760.
14. Papakostopoulos D, Fotiou F, Hart JC, Banerji NK. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol. 1989;74(1):1-10. (Pubitemid 19014990)
15. Forooghian F, Sproule M, Westall C, et al. Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies. Doc Ophthalmol. 2006; 113(2):123-132.
16. Gundogan FC, Demirkaya S, Sobaci G. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis? a structural and functional evaluation. Invest Ophthalmol Vis Sci. 2007;48(12):5773-5781. (Pubitemid 351260883)
17. Gills JP Jr. Electroretinographic abnormalities and advanced multiple sclerosis. Invest Ophthalmol. 1966;5(6):555-559.
18. Holländer H, Bisti S, Maffei L, Hebel R. Electroretinographic responses and retrograde changes of retinal morphology after intracranial optic nerve section: a quantitative analysis in the cat. Exp Brain Res. 1984;55(3):483-493. (Pubitemid 14085203)
19. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME. Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci. 2001;42(5): 975-982. (Pubitemid 32289792)
20. Williams RR, Cusato K, Raven MA, Reese BE. Organization of the inner retina following early elimination of the retinal ganglion cell population: effects on cell numbers and stratification patterns. Vis Neurosci. 2001;18(2):233-244. (Pubitemid 32472429)
21. Dawson WW, Maida TM, Rubin ML. Human pattern-evoked retinal responses are altered by optic atrophy. Invest Ophthalmol Vis Sci. 1982;22(6):796-803. (Pubitemid 12051308)
22. Kaufman D, Celesia GG. Simultaneous recording of pattern electroretinogram and visual evoked responses in neuro-ophthalmologic disorders. Neurology. 1985; 35(5):644-651. (Pubitemid 15067016)
23. Seiple W, Price MJ, Kupersmith M, Siegel IM, Carr RE. The pattern electroretinogram in optic nerve disease. Ophthalmology. 1983;90(9):1127-1132. (Pubitemid 13010866)
24. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 2007;69(16):1603-1609. (Pubitemid 350287144)
25. Grazioli E, Zivadinov R, Weinstock-Guttman B, et al. Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci. 2008;268(1-2):12-17. (Pubitemid 351389462)
26. Siger M, Dziegielewski K, Jasek L, et al. Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J Neurol. 2008;255(10):1555-1560.
27. Dörr J, Wernecke KD, Bock M, et al. Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One. 2011;6(4):e18132.
28. Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, García-Layana A, Bejarano B, Villoslada P. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 2007;68(18):1488-1494. (Pubitemid 46685919)
29. Syc SB, Warner CV, Hiremath GS, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler. 2010;16(7):829-839.
30. Warner CV, Syc SB, Stankiewicz AM, et al. The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials. PLoS One. 2011;6(8):e22947.
31. Whitwell JL, Crum WR, Watt HC, Fox NC. Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol. 2001;22(8):1483-1489. (Pubitemid 32862259)
32. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292-302.
33. Lublin FD, Reingold SC; National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology. 1996;46(4):907-911. (Pubitemid 26134623)
34. Carass A, Cuzzocreo J, Wheeler MB, Bazin PL, Resnick SM, Prince JL. Simple paradigm for extra-cerebral tissue removal: algorithm and analysis. Neuroimage. 2011;56(4):1982-1992.
35. Shiee N, Bazin PL, Ozturk A, Reich DS, Calabresi PA, Pham DL. A topologypreserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage. 2010;49(2):1524-1535.
36. Bender R, Lange S. Adjusting for multiple testing: when and how? J Clin Epidemiol. 2001;54(4):343-349. (Pubitemid 32303457)
37. Geurts JJ, Pouwels PJ, Uitdehaag BM, Polman CH, Barkhof F, Castelijns JA. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236(1):254-260. (Pubitemid 40853320)
38. Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol. 2007;254(9):1212-1220. (Pubitemid 350112349)
39. Calabrese M, De Stefano N, Atzori M, et al. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol. 2007;64(10):1416-1422. (Pubitemid 47572665)
40. Rucker CW. Sheathing of the retinal veins in multiple sclerosis: review of pertinent literature. Mayo Clin Proc. 1972;47(5):335-340.
41. Engell T, Hvidberg A, Uhrenholdt A. Multiple sclerosis: periphlebitis retinalis et cerebro-spinalis: a correlation between periphlebitis retinalis and abnormal technetium brain scintigraphy. Acta Neurol Scand. 1984;69(5):293-297. (Pubitemid 14106163)
42. Petzold A, de Boer JF, Schippling S, et al. Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2010; 9(9):921-932.
43. Werner JS, Keltner JL, Zawadzki RJ, Choi SS. Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies. Eye (Lond). 2011;25(3):279-289.